


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
0.00%
+34.26%
-13.08%
-2.17%
-2.59%
MASI
Masimo Corporation C
$174.92
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
MASI Price Performance
$142.7 (+22.58%)
$140.94 (+24.11%)
$140.36 (+24.62%)
$183.46 (-4.65%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
MASI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MASI Street Sentiment is extremely bullish and have positive views on the near-term outlook
MASI has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Recent Upgrades and Downgrades
BUY
Date
Action
Rating
Firm
Jan 01, 2026
Reiterate
Buy
Wells Fargo
Dec 04, 2025
Reiterate
Buy
BTIG
Nov 24, 2025
Reiterate
Buy
BTIG
Nov 17, 2025
Initiate
Neutral
B of A Securities
Nov 06, 2025
Reiterate
Overweight
Wells Fargo
What is MASI current stock price?
What are MASI stock strengths?
What is MASI Risk Level?
What is MASI market cap and volume?
What is MASI current Stock IQ?
Should I buy MASI stock right now?
Is MASI a Strong Buy right now?
What does a 'Strong Buy' rating mean for MASI?
What does a 'Strong Sell' rating mean for MASI?
What factors influence MASI's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
0.00%
+34.26%
-13.08%
-2.17%
-2.59%
MASI
Masimo Corporation C
Current Price
$174.92

MASI Price Performance
$142.7 (+22.58%)
$140.94 (+24.11%)
$140.36 (+24.62%)
$183.46 (-4.65%)
MASI Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
MASI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MASI Street Sentiment is extremely bullish and have positive views on the near-term outlook
MASI has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
BUY
Jan 01, 2026
Reiterate
Buy
Wells Fargo
Dec 04, 2025
Reiterate
Buy
BTIG
Nov 24, 2025
Reiterate
Buy
BTIG
Nov 17, 2025
Initiate
Neutral
B of A Securities
Nov 06, 2025
Reiterate
Overweight
Wells Fargo
Nov 06, 2025
Upgrade
Buy
Zacks
MASI Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
MASI Latest Analysis
Danaher Agrees to Buy Medical Tech Firm Masimo for $9.9 Billion. Danaher Corp. agreed to buy US medical technology firm Masimo Corp. in a deal with an enterprise value of about $9.9 billion.
Today
Danaher Strengthens Diagnostics Capabilities With $9.9 Bln Masimo Acquisition . (RTTNews) - Danaher Corp. (DHR) a science and technology innovator announced Tuesday that it has entered into a definitive agreement to acquire Masimo Corp. (MASI) a specialty diagnostics provider primarily in acute care settings.
Today
Masimo Stock Soars As Danaher Closes In On Blockbuster Deal. ) is reportedly nearing a roughly $9.9 billion acquisition of MASI) a move that follows significant governance changes at the driven by activist investors.A transaction for the California-based Masimo could be announced as early as Tuesday the Financial Times provided there are no last-minute complications according to people familiar with the matter.The deal represents a notable premium to Masimo’.s nearly $7 billion market cap
Today
Danaher Said to Near $10 Billion Deal for Masimo FT Reports. Danaher Corp. is nearing a roughly $10 billion deal to acquire US medical technology firm Masimo Corp. the Financial Times reported citing unidentified people familiar with the matter.
Today
Heres Why You Should Add Masimo Stock to Your Portfolio Now. MASI targets 7%-10% revenue growth through 2028 sharp margin expansion and rising cash flow as intelligent monitoring and partnerships gain traction.
Wed Feb 4, 2026
Why Masimo (MASI) is a Top Growth Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Wed Feb 4, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MASI Stock trends
MASI Stock performance
MASI Stock analysis
MASI investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.